Abstract
Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Modulation of the Immune Response by Targeting Endothelial Cells
Volume: 6 Issue: 2
Author(s): Maria Manunta, Peng Hong Tan and Andrew John Timothy George
Affiliation:
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Abstract: Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Export Options
About this article
Cite this article as:
Manunta Maria, Hong Tan Peng and John Timothy George Andrew, Modulation of the Immune Response by Targeting Endothelial Cells, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (2) . https://dx.doi.org/10.2174/187152307780598045
DOI https://dx.doi.org/10.2174/187152307780598045 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets (Discontinued) Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
Current Medicinal Chemistry Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential
Vascular Disease Prevention (Discontinued) Fenofibrate and Telmisartan in the Management of Abdominal Aortic Aneurysm
Current Drug Targets Factor VIII Levels are Associated with Ischemic Stroke, Stroke Subtypes and Neurological Worsening
Current Neurovascular Research Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews All Cognitive Systems but Speed and Visuospatial Functions Reduce the Effect of CSF Pathology on Other Systems
Current Alzheimer Research Schizophrenia: Causes and Treatments
Current Pharmaceutical Design Withdrawal Notice: Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease
Current Drug Targets Effect of Antipsychotic Drugs on Cerebrovascular Morbidity and Mortality: A Systematic Review
Current Drug Therapy Treatment of Leukoaraiosis: A Futuristic View
Current Drug Targets Macrovascular Protecting Effects of Berberine through Anti-inflammation and Intervention of BKCa in Type 2 Diabetes Mellitus Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Vascular Adenosine Receptors; Potential Clinical Applications
Current Vascular Pharmacology Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design Repurposed Drugs in Metabolic Disorders
Current Topics in Medicinal Chemistry Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions
Current Pharmaceutical Design Impact of Macrophages in Atherosclerosis
Current Medicinal Chemistry Diabetic Medications in Pregnancy
Current Diabetes Reviews